Oramed Pharmaceuticals Inc (ORMP)

Mar 24, 2025

Oral Biologics Market Is Booming Worldwide 2025-2032 | Biocon - openPR.com

Mar 24, 2025

Mar 21, 2025

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView

Mar 21, 2025

Mar 13, 2025

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential - Simply Wall St

Mar 13, 2025

Mar 12, 2025

Oramed Pharmaceuticals Stock Plummets After Insulin Test Results - The Wall Street Journal

Mar 12, 2025

Mar 11, 2025

Tianhui Biotech and Oramed Pharmaceuticals’ Investment in OraTech Pharmaceuticals - Global Legal Chronicle

Mar 11, 2025

Mar 08, 2025

AllPennyStocks.com Releases a Special Report on Oramed Pharmaceuticals Inc. - ACCESS Newswire

Mar 08, 2025

Mar 04, 2025

Oramed advances oral insulin, plans Phase 3 trial and dividend - Investing.com

Mar 04, 2025

Mar 04, 2025

Oramed advances oral insulin, plans Phase 3 trial and dividend By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Oramed Pharmaceuticals Issues Letter to Shareholders - PR Newswire

Mar 04, 2025

Mar 03, 2025

ORMP stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

ORMP stock touches 52-week low at $2 amid market challenges - Investing.com

Mar 03, 2025

Mar 01, 2025

Short Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Expands By 149.0% - Armenian Reporter

Mar 01, 2025

Feb 28, 2025

OraMed Enters Global Licensing Deal for Lidocaine Product By Investing.com - Investing.com Australia

Feb 28, 2025

Feb 27, 2025

Oramed Pharmaceuticals (ORMP) to Release Quarterly Earnings on Wednesday - MarketBeat

Feb 27, 2025

Feb 27, 2025

OraMed Enters Global Licensing Deal for Lidocaine Product - Investing.com India

Feb 27, 2025

Feb 27, 2025

Rep. Brad Knott Sells Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Shares - MarketBeat

Feb 27, 2025

Feb 26, 2025

Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock - Benzinga

Feb 26, 2025

Feb 26, 2025

Congress Trade: Representative Brad Knott Just Disclosed New Stock Trades - Quiver Quantitative

Feb 26, 2025

Feb 22, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Downgraded to Sell Rating by StockNews.com - MarketBeat

Feb 22, 2025

Feb 17, 2025

227,239 Shares in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Acquired by Peapod Lane Capital LLC - MarketBeat

Feb 17, 2025

Feb 15, 2025

Oramed announces spinoff of protein drug technology - MSN

Feb 15, 2025

Feb 12, 2025

OraTech to pioneer oral insulin with $75 million investment - MSN

Feb 12, 2025

Feb 12, 2025

Oramed Pharmaceuticals : Ancillary Agreement Completion Protocol and Supplemental Agreement - Marketscreener.com

Feb 12, 2025

Feb 11, 2025

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025

Feb 11, 2025

Oramed Pharm Amends Joint Venture for OraTech Launch - TipRanks

Feb 11, 2025

Feb 11, 2025

Oramed (ORMP) Stock Skyrockets Amid JV Development Plans - Stocks Telegraph

Feb 11, 2025

Feb 11, 2025

OraTech to pioneer oral insulin with $75 million investment By Investing.com - Investing.com South Africa

Feb 11, 2025

Feb 11, 2025

Oramed Pharmaceuticals Forms Joint Venture to Commercialize Oral Insulin; Shares Rise - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

Oramed Pharmaceuticals to Spin Off Its Protein Oral Delivery Technology - Contract Pharma

Feb 11, 2025

Feb 11, 2025

Oramed stock soars on spinoff plans (ORMP:NASDAQ) - Seeking Alpha

Feb 11, 2025

Feb 11, 2025

Oramed Announces Joint Venture To Develop And Commercialize Oral Insulin -February 11, 2025 at 09:17 am EST - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin - PR Newswire

Feb 11, 2025

Feb 11, 2025

Charting the Course: Viking Therapeutics Inc’s VKTX Stock Prospects - The InvestChronicle

Feb 11, 2025

Feb 11, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Rating Lowered by StockNews.com - MarketBeat

Feb 11, 2025

Feb 10, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Below 200 Day Moving AverageTime to Sell? - MarketBeat

Feb 10, 2025

Feb 04, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat

Feb 04, 2025

Jan 31, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Cross Below Two Hundred Day Moving Average – Here’s Why - Defense World

Jan 31, 2025

Jan 24, 2025

Oramed Pharmaceuticals Extends Maturity Date of Senior Secured Promissory Note in Recent Amendment - Defense World

Jan 24, 2025

Jan 22, 2025

Oramed Pharmaceuticals extends loan maturity, acquires Scilex shares - Investing.com

Jan 22, 2025

Jan 21, 2025

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025 - The Manila Times

Jan 21, 2025

Jan 18, 2025

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Sees Significant Decrease in Short Interest - MarketBeat

Jan 18, 2025

Jan 14, 2025

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded to “Hold” at StockNews.com - Defense World

Jan 14, 2025